HuGE Literature Finder
Records 1-30
|
A tailored next-generation sequencing panel identified distinct subtypes of wildtype IDH and TERT promoter glioblastomas.
Cancer science 2020 Aug . Higa Nayuta, Akahane Toshiaki, Yokoyama Seiya, Yonezawa Hajime, Uchida Hiroyuki, Takajo Tomoko, Kirishima Mari, Hamada Taiji, Matsuo Kei, Fujio Shingo, Hanada Tomoko, Hosoyama Hiroshi, Yonenaga Masanori, Sakamoto Akihisa, Hiraki Tsubasa, Tanimoto Akihide, Yoshimoto Ko |
|
Germline cancer predisposition variants and pediatric glioma: a population-based study in California.
Neuro-oncology 2020 Jan . Muskens Ivo S, de Smith Adam J, Zhang Chenan, Hansen Helen M, Morimoto Libby, Metayer Catherine, Ma Xiaomei, Walsh Kyle M, Wiemels Joseph |
|
Genomic analysis of primary and recurrent gliomas reveals clinical outcome related molecular features.
Scientific reports 2019 Nov 9 (1): 16058. Zhang Longbo, Liu Zhiqiang, Li Jin, Huang Tianxiang, Wang Ying, Chang Lianpeng, Zheng Wenjie, Ma Yujie, Chen Fenghua, Gong Xuan, Yuan Qianying, Teaw Shannon, Fang Xinqi, Song Tao, Huo Lei, Li Xi, Xia Xuefeng, Liu Zhixiong, Wu J |
|
Tissue-specific microRNA expression alters cancer susceptibility conferred by a TP53 noncoding variant.
Nature communications 2019 Nov 10 (1): 5061. Deng Qipan, Hu Hui, Yu Xinfang, Liu Shuanglin, Wang Lei, Chen Weiqun, Zhang Chi, Zeng Zhaoyang, Cao Ya, Xu-Monette Zijun Y, Li Ling, Zhang Mingzhi, Rosenfeld Steven, Bao Shideng, Hsi Eric, Young Ken H, Lu Zhongxin, Li Yo |
|
High frequency of H3K27M immunopositivity in adult thalamic glioblastoma.
Neuropathology : official journal of the Japanese Society of Neuropathology 2019 Apr 39 (2): 78-84. Rao Shilpa, Kanuri Nandaki N, Nimbalkar Vidya, Arivazhagan Arimappamagan, Santosh Va |
|
von Willebrand Factor Gene Expression in Primary Lower Grade Glioma: Mutually Co-Occurring Mutations in von Willebrand Factor, ATRX, and TP53.
Brain tumor research and treatment 2019 Apr 7 (1): 33-38. Lehrer Steven, Rheinstein Peter H, Green Sheryl, Rosenzweig Kenneth |
|
The genetic landscape of anaplastic pleomorphic xanthoastrocytoma.
Brain pathology (Zurich, Switzerland) 2019 Jan 29 (1): 85-96. Phillips Joanna J, Gong Henry, Chen Katharine, Joseph Nancy M, van Ziffle Jessica, Bastian Boris C, Grenert James P, Kline Cassie N, Mueller Sabine, Banerjee Anuradha, Nicolaides Theodore, Gupta Nalin, Berger Mitchel S, Lee Han S, Pekmezci Melike, Tihan Tarik, Bollen Andrew W, Perry Arie, Shieh Joseph T C, Solomon David |
|
Whole exome sequencing-based analysis to identify DNA damage repair deficiency as a major contributor to gliomagenesis in adult diffuse gliomas.
Journal of neurosurgery 2019 04 1-12. Ülgen Ege, Can Özge, Bilguvar Kaya, Oktay Yavuz, Akyerli Cemaliye B, Danyeli Ayça Ersen, Yakicier M Cengiz, Sezerman O Ugur, Pamir M Necmettin, Özduman Kor |
|
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse gliomarwith molecular genetic features of primary glioblastoma.
Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
|
Molecular Study of Long-Term Survivors of Glioblastoma by Gene-Targeted Next-Generation Sequencing.
Journal of neuropathology and experimental neurology 2018 Aug 77 (8): 710-716. Cantero Diana, Rodríguez de Lope Ángel, Moreno de la Presa Raquel, Sepúlveda Juan M, Borrás José M, Castresana Javier S, D'Haene Nicky, García Juan F, Salmon Isabelle, Mollejo Manuela, Rey Juan A, Hernández-Laín Aurelio, Meléndez Bárba |
|
Survival in males with glioma and gastric adenocarcinoma correlates with mutant p53 residual transcriptional activity.
JCI insight 2018 Aug 3 (15): . Fischer Nicholas W, Prodeus Aaron, Gariépy Je |
|
IDH-mutated astrocytomas with 19q-loss constitute a subgroup that confers better prognosis.
Cancer science 2018 May . Otani Ryohei, Uzuka Takeo, Higuchi Fumi, Matsuda Hadzki, Nomura Masashi, Tanaka Shota, Mukasa Akitake, Ichimura Koichi, Kim Phyo, Ueki Keisu |
|
The clinicopathological and prognostic significance of TP53 alteration in K27M mutated gliomas: an individual-participant data meta-analysis.
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2018 Apr . Dong Chengya, Yuan Zhengrong, Li Qi, Wang Yaj |
|
Frequency of Somatic TP53 Mutations in Combination with Known Pathogenic Mutations in Colon Adenocarcinoma, Non-Small Cell Lung Carcinoma, and Gliomas as Identified by Next-Generation Sequencing.
Neoplasia (New York, N.Y.) 2018 Feb 20 (3): 256-262. Shajani-Yi Zahra, de Abreu Francine B, Peterson Jason D, Tsongalis Gregory |
|
Blood-tissue analysis of TP53 polymorphisms and survival of patients with glioma.
Journal of neurosurgical sciences 2018 Jan . Panciani Pier P, Giordana Maria T, Gallone Salvatore, Muratori Andrea, Rotunno Rosaria, Migliorati Karol, Spena Giannantonio, Ducati Alessandro, Fontanella Mar |
|
Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma.
Frontiers in oncology 2018 8 413. Li Jinghui, Liu Xiaoyu, Qiao Yu, Qi Renli, Liu Shunjin, Guo Jing, Gui Yang, Li Juanjuan, Yu Hual |
|
Racial Disparities in the Molecular Landscape of Cancer.
Anticancer research 2018 04 38 (4): 2235-2240. Heath Elisabeth I, Lynce Filipa, Xiu Joanne, Ellerbrock Angela, Reddy Sandeep K, Obeid Elias, Liu Stephen V, Bollig-Fischer Aliccia, Separovic Duska, Vanderwalde A |
|
Paradoxical prognostic impact of TERT promoter mutations in gliomas depends on different histological and genetic backgrounds.
CNS neuroscience & therapeutics 2017 Oct 23 (10): 790-797. You Hao, Wu Yao, Chang Kai, Shi Xiao, Chen Xin-Da, Yan Wei, Li R |
|
IDH mutation status trumps the Pignatti risk score as a prognostic marker in low-grade gliomas.
Journal of neuro-oncology 2017 Sep . Etxaniz Olatz, Carrato Cristina, de Aguirre Itziar, Queralt Cristina, Muñoz Ana, Ramirez José L, Rosell Rafael, Villà Salvador, Diaz Rocio, Estival Ana, Teixidor Pilar, Indacochea Alberto, Ahjal Sara, Vilà Laia, Balañá Car |
|
The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma.
Journal of neuro-oncology 2017 Sep . Liu Xiang, Mangla Rajiv, Tian Wei, Qiu Xing, Li Dongmei, Walter Kevin A, Ekholm Sven, Johnson Mahlon |
|
Molecular differences in IDH wildtype glioblastoma according to MGMT promoter methylation.
Neuro-oncology 2017 Aug . Kessler Tobias, Sahm Felix, Sadik Ahmed, Stichel Damian, Hertenstein Anne, Reifenberger Guido, Zacher Angela, Sabel Michael, Tabatabai Ghazaleh, Steinbach Joachim, Sure Ulrich, Krex Dietmar, Grosu Anca-L, Bewerunge-Hudler Melanie, Jones David, Pfister Stefan M, Weller Michael, Opitz Christiane, Bendszus Martin, von Deimling Andreas, Platten Michael, Wick Wolfga |
|
Sexual dimorphism in glioma glycolysis underlies sex differences in survival.
JCI insight 2017 Aug 2 (15): . Ippolito Joseph E, Yim Aldrin Kay-Yuen, Luo Jingqin, Chinnaiyan Prakash, Rubin Joshua |
|
High prevalence of TP53 mutations is associated with poor survival and an EMT signature in gliosarcoma patients.
Experimental & molecular medicine 2017 Apr 49 (4): e317. Cho Sung-Yup, Park Changho, Na Deukchae, Han Jee Yun, Lee Jieun, Park Ok-Kyoung, Zhang Chengsheng, Sung Chang Ohk, Moon Hyo Eun, Kim Yona, Kim Jeong Hoon, Kim Jong Jae, Khang Shin Kwang, Nam Do-Hyun, Choi Jung Won, Suh Yeon-Lim, Kim Dong Gyu, Park Sung Hye, Youn Hyewon, Yun Kyuson, Kim Jong-Il, Lee Charles, Paek Sun Ha, Park Hans |
|
The ribosomal protein gene RPL5 is a haploinsufficient tumor suppressor in multiple cancer types.
Oncotarget 2017 Jan . Fancello Laura, Kampen Kim R, Hofman Isabel Jf, Verbeeck Jelle, De Keersmaecker K |
|
Isocitrate Dehydrogenase Mutations are Better Prognostic Marker than O6-methylguanine-DNA Methyltransferase Promoter Methylation in Glioblastomas - a Retrospective, Single-centre Molecular Genetics Study of Gliomas.
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti 2017 30 (5): 361-371. Houdova Megova M, Drábek J, Dwight Z, Trojanec R, Koudeláková V, Vrbková J, Kalita O, Mlcochova S, Rabcanova M, Hajdúch |
|
Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters.
Journal of neuro-oncology 2016 Nov . Nakae Shunsuke, Murayama Kazuhiro, Sasaki Hikaru, Kumon Masanobu, Nishiyama Yuya, Ohba Shigeo, Adachi Kazuhide, Nagahisa Shinya, Hayashi Takuro, Inamasu Joji, Abe Masato, Hasegawa Mitsuhiro, Hirose Yuic |
|
Not all 1p/19q non-codeleted oligodendroglial tumors are astrocytic.
Oncotarget 2016 Oct 7 (40): 64615-64630. Li Yan-Xi, Shi Zhifeng, Aibaidula Abudumijiti, Chen Hong, Tang Qisheng, Li Kay Ka-Wai, Chung Nellie Yuk-Fei, Chan Danny Tat-Ming, Poon Wai Sang, Mao Ying, Wu Jinsong, Zhou Liangfu, Chan Aden Ka-Yin, Ng Ho-Keu |
|
GBM-associated mutations and altered protein expression are more common in young patients.
Oncotarget 2016 Aug . Ferguson Sherise D, Xiu Joanne, Weathers Shiao-Pei, Zhou Shouhao, Kesari Santosh, Weiss Stephanie E, Verhaak Roeland G, Hohl Raymond J, Barger Geoffrey R, Reddy Sandeep K, Heimberger Amy |
|
The Correlation Between 1p/19q Codeletion, IDH1 Mutation, p53 Overexpression and Their Prognostic Roles in 41 Turkish Anaplastic Oligodendroglioma Patients.
Turkish neurosurgery 2016 Aug . Hacisalihoglu Payam, Kucukodaci Zafer, Gundogdu Gokcen, Bilgic Bil |
|
TP53 codon 72 polymorphism may predict early tumour progression in paediatric pilocytic astrocytoma.
Oncotarget 2016 Jun . Mascelli Samantha, Nozza Paolo, Jones David T W, Colin Carole, Pistorio Angela, Milanaccio Claudia, Ravegnani Marcello, Consales Alessandro, Witt Olaf, Morana Giovanni, Cama Armando, Capra Valeria, Biassoni Roberto, Pfister Stefan M, Figarella-Branger Dominique, Garrè Maria Luisa, Raso Alessand |
|
A novel TP53 variant (rs78378222 A > C) in the polyadenylation signal is associated with increased cancer susceptibility: evidence from a meta-analysis.
Oncotarget 2016 May 7 (22): 32854-65. Wang Ying, Wu Xue-Song, He Jing, Ma Tianjiao, Lei Wei, Shen Zhen- |
|
Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma.
Journal of neuro-oncology 2016 May 127 (3): 483-92. Ghasimi Soma, Wibom Carl, Dahlin Anna M, Brännström Thomas, Golovleva Irina, Andersson Ulrika, Melin Beatri |
|
Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas.
Brain tumor pathology 2016 Mar . Takano Shingo, Ishikawa Eiichi, Sakamoto Noriaki, Matsuda Masahide, Akutsu Hiroyoshi, Noguchi Masayuki, Kato Yukinari, Yamamoto Tetsuya, Matsumura Aki |
|
Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma.
The oncologist 2016 Feb . Fathi Amir T, Nahed Brian V, Wander Seth A, Iafrate A John, Borger Darrell R, Hu Ranliang, Thabet Ashraf, Cahill Daniel P, Perry Ashley M, Joseph Christelle P, Muzikansky Alona, Chi Andrew |
|
IDH mutation is associated with higher risk of malignant transformation in low-grade glioma.
Journal of neuro-oncology 2016 Jan . Leu Severina, von Felten Stefanie, Frank Stephan, Boulay Jean-Louis, Mariani Lui |
|
Chromosome 17p Homodisomy Is Associated With Better Outcome in 1p19q Non-Codeleted and IDH-Mutated Gliomas.
The oncologist 2016 09 21 (9): 1131-5. Labussière Marianne, Rahimian Amithys, Giry Marine, Boisselier Blandine, Schmitt Yohann, Polivka Marc, Mokhtari Karima, Delattre Jean-Yves, Idbaih Ahmed, Labreche Karim, Alentorn Agusti, Sanson Ma |
|
Spatial genomic heterogeneity in diffuse intrinsic pontine and midline high-grade glioma: implications for diagnostic biopsy and targeted therapeutics.
Acta neuropathologica communications 2016 4 (1): 1. Hoffman Lindsey M, DeWire Mariko, Ryall Scott, Buczkowicz Pawel, Leach James, Miles Lili, Ramani Arun, Brudno Michael, Kumar Shiva Senthil, Drissi Rachid, Dexheimer Phillip, Salloum Ralph, Chow Lionel, Hummel Trent, Stevenson Charles, Lu Q Richard, Jones Blaise, Witte David, Aronow Bruce, Hawkins Cynthia E, Fouladi Mary |
|
Epidermal growth factor receptor overexpression is common and not correlated to gene copy number in ependymoma.
Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2015 Dec . Friedrich Carsten, von Bueren André O, Kolevatova Larissa, Bernreuther Christian, Grob Tobias, Sepulveda-Falla Diego, van den Boom Leander, Westphal Manfred, Simon Ronald, Glatzel Mark |
|
ATRX loss in adult supratentorial diffuse astrocytomas correlates with p53 over expression and IDH1 mutation and predicts better outcome in p53 accumulated patients.
Histology and histopathology 2015 Sep 11664. Shao Li-Wei, Pan Yi, Qi Xue-Ling, Li Yong-Xiao, Ma Xiao-Long, Yi Wei-Ning, Zhang Jing, Zhong Yan-Feng, Chang Qi |
|
Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
Human pathology 2015 Sep 46 (9): 1323-30. Vizcaíno M Adelita, Shah Smit, Eberhart Charles G, Rodriguez Fausto |
|
Comprehensive portrait of recurrent glioblastoma multiforme in molecular and clinical characteristics.
Oncotarget 2015 Sep . Li Rui, Chen Xincheng, You Yongping, Wang Xiefeng, Liu Yanwei, Hu Qi, Yan W |
|
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
|
CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma.
Journal of neuro-oncology 2015 Aug . Dahlin Anna M, Hollegaard Mads V, Wibom Carl, Andersson Ulrika, Hougaard David M, Deltour Isabelle, Hjalmars Ulf, Melin Beatri |
|
Immunohistochemical profiles of IDH1, MGMT and P53: practical significance for prognostication of patients with diffuse gliomas.
Neuropathology : official journal of the Japanese Society of Neuropathology 2015 Aug 35 (4): 324-35. Ogura Ryosuke, Tsukamoto Yoshihiro, Natsumeda Manabu, Isogawa Mizuho, Aoki Hiroshi, Kobayashi Tsutomu, Yoshida Seiichi, Okamoto Kouichiro, Takahashi Hitoshi, Fujii Yukihiko, Kakita Akiyos |
|
IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
Oncotarget 2015 Jul . Leeper Heather E, Caron Alissa A, Decker Paul A, Jenkins Robert B, Lachance Daniel H, Giannini Cateri |
|
The H3.3 K27M mutation results in a poorer prognosis in brainstem gliomas than thalamic gliomas in adults.
Human pathology 2015 Jul . Feng Jie, Hao Shuyu, Pan Changcun, Wang Yu, Wu Zhen, Zhang Junting, Yan Hai, Zhang Liwei, Wan Ho |
|
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.
The New England journal of medicine 2015 Jun 372 (26): 2481-98. , Brat Daniel J, Verhaak Roel G W, Aldape Kenneth D, Yung W K Alfred, Salama Sofie R, Cooper Lee A D, Rheinbay Esther, Miller C Ryan, Vitucci Mark, Morozova Olena, Robertson A Gordon, Noushmehr Houtan, Laird Peter W, Cherniack Andrew D, Akbani Rehan, Huse Jason T, Ciriello Giovanni, Poisson Laila M, Barnholtz-Sloan Jill S, Berger Mitchel S, Brennan Cameron, Colen Rivka R, Colman Howard, Flanders Adam E, Giannini Caterina, Grifford Mia, Iavarone Antonio, Jain Rajan, Joseph Isaac, Kim Jaegil, Kasaian Katayoon, Mikkelsen Tom, Murray Bradley A, O'Neill Brian Patrick, Pachter Lior, Parsons Donald W, Sougnez Carrie, Sulman Erik P, Vandenberg Scott R, Van Meir Erwin G, von Deimling Andreas, Zhang Hailei, Crain Daniel, Lau Kevin, Mallery David, Morris Scott, Paulauskis Joseph, Penny Robert, Shelton Troy, Sherman Mark, Yena Peggy, Black Aaron, Bowen Jay, Dicostanzo Katie, Gastier-Foster Julie, Leraas Kristen M, Lichtenberg Tara M, Pierson Christopher R, Ramirez Nilsa C, Taylor Cynthia, Weaver Stephanie, Wise Lisa, Zmuda Erik, Davidsen Tanja, Demchok John A, Eley Greg, Ferguson Martin L, Hutter Carolyn M, Mills Shaw Kenna R, Ozenberger Bradley A, Sheth Margi, Sofia Heidi J, Tarnuzzer Roy, Wang Zhining, Yang Liming, Zenklusen Jean Claude, Ayala Brenda, Baboud Julien, Chudamani Sudha, Jensen Mark A, Liu Jia, Pihl Todd, Raman Rohini, Wan Yunhu, Wu Ye, Ally Adrian, Auman J Todd, Balasundaram Miruna, Balu Saianand, Baylin Stephen B, Beroukhim Rameen, Bootwalla Moiz S, Bowlby Reanne, Bristow Christopher A, Brooks Denise, Butterfield Yaron, Carlsen Rebecca, Carter Scott, Chin Lynda, Chu Andy, Chuah Eric, Cibulskis Kristian, Clarke Amanda, Coetzee Simon G, Dhalla Noreen, Fennell Tim, Fisher Sheila, Gabriel Stacey, Getz Gad, Gibbs Richard, Guin Ranabir, Hadjipanayis Angela, Hayes D Neil, Hinoue Toshinori, Hoadley Katherine, Holt Robert A, Hoyle Alan P, Jefferys Stuart R, Jones Steven, Jones Corbin D, Kucherlapati Raju, Lai Phillip H, Lander Eric, Lee Semin, Lichtenstein Lee, Ma Yussanne, Maglinte Dennis T, Mahadeshwar Harshad S, Marra Marco A, Mayo Michael, Meng Shaowu, Meyerson Matthew L, Mieczkowski Piotr A, Moore Richard A, Mose Lisle E, Mungall Andrew J, Pantazi Angeliki, Parfenov Michael, Park Peter J, Parker Joel S, Perou Charles M, Protopopov Alexei, Ren Xiaojia, Roach Jeffrey, Sabedot Thaís S, Schein Jacqueline, Schumacher Steven E, Seidman Jonathan G, Seth Sahil, Shen Hui, Simons Janae V, Sipahimalani Payal, Soloway Matthew G, Song Xingzhi, Sun Huandong, Tabak Barbara, Tam Angela, Tan Donghui, Tang Jiabin, Thiessen Nina, Triche Timothy, Van Den Berg David J, Veluvolu Umadevi, Waring Scot, Weisenberger Daniel J, Wilkerson Matthew D, Wong Tina, Wu Junyuan, Xi Liu, Xu Andrew W, Yang Lixing, Zack Travis I, Zhang Jianhua, Aksoy B Arman, Arachchi Harindra, Benz Chris, Bernard Brady, Carlin Daniel, Cho Juok, DiCara Daniel, Frazer Scott, Fuller Gregory N, Gao JianJiong, Gehlenborg Nils, Haussler David, Heiman David I, Iype Lisa, Jacobsen Anders, Ju Zhenlin, Katzman Sol, Kim Hoon, Knijnenburg Theo, Kreisberg Richard Bailey, Lawrence Michael S, Lee William, Leinonen Kalle, Lin Pei, Ling Shiyun, Liu Wenbin, Liu Yingchun, Liu Yuexin, Lu Yiling, Mills Gordon, Ng Sam, Noble Michael S, Paull Evan, Rao Arvind, Reynolds Sheila, Saksena Gordon, Sanborn Zack, Sander Chris, Schultz Nikolaus, Senbabaoglu Yasin, Shen Ronglai, Shmulevich Ilya, Sinha Rileen, Stuart Josh, Sumer S Onur, Sun Yichao, Tasman Natalie, Taylor Barry S, Voet Doug, Weinhold Nils, Weinstein John N, Yang Da, Yoshihara Kosuke, Zheng Siyuan, Zhang Wei, Zou Lihua, Abel Ty, Sadeghi Sara, Cohen Mark L, Eschbacher Jenny, Hattab Eyas M, Raghunathan Aditya, Schniederjan Matthew J, Aziz Dina, Barnett Gene, Barrett Wendi, Bigner Darell D, Boice Lori, Brewer Cathy, Calatozzolo Chiara, Campos Benito, Carlotti Carlos Gilberto, Chan Timothy A, Cuppini Lucia, Curley Erin, Cuzzubbo Stefania, Devine Karen, DiMeco Francesco, Duell Rebecca, Elder J Bradley, Fehrenbach Ashley, Finocchiaro Gaetano, Friedman William, Fulop Jordonna, Gardner Johanna, Hermes Beth, Herold-Mende Christel, Jungk Christine, Kendler Ady, Lehman Norman L, Lipp Eric, Liu Ouida, Mandt Randy, McGraw Mary, Mclendon Roger, McPherson Christopher, Neder Luciano, Nguyen Phuong, Noss Ardene, Nunziata Raffaele, Ostrom Quinn T, Palmer Cheryl, Perin Alessandro, Pollo Bianca, Potapov Alexander, Potapova Olga, Rathmell W Kimryn, Rotin Daniil, Scarpace Lisa, Schilero Cathy, Senecal Kelly, Shimmel Kristen, Shurkhay Vsevolod, Sifri Suzanne, Singh Rosy, Sloan Andrew E, Smolenski Kathy, Staugaitis Susan M, Steele Ruth, Thorne Leigh, Tirapelli Daniela P C, Unterberg Andreas, Vallurupalli Mahitha, Wang Yun, Warnick Ronald, Williams Felicia, Wolinsky Yingli, Bell Sue, Rosenberg Mara, Stewart Chip, Huang Franklin, Grimsby Jonna L, Radenbaugh Amie J, Zhang Jian |
|
Investigation of established genetic risk variants for glioma in prediagnostic samples from a population-based nested case-control study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 May 24 (5): 810-6. Wibom Carl, Späth Florentin, Dahlin Anna M, Langseth Hilde, Hovig Eivind, Rajaraman Preetha, Johannesen Tom Børge, Andersson Ulrika, Melin Beatri |
|
Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas.
Brain tumor pathology 2015 Apr 32 (2): 99-104. Sonoda Yukihiko, Shibahara Ichiyoo, Kawaguchi Tomohiro, Saito Ryuta, Kanamori Masayuki, Watanabe Mika, Suzuki Hiroyoshi, Kumabe Toshihiro, Tominaga Tei |
|
Gene mutation profiling of primary glioblastoma through multiple tumor biopsy guided by 1H-magnetic resonance spectroscopy.
International journal of clinical and experimental pathology 2015 8 (5): 5327-35. Tang Chao, Guo Jun, Chen Hong, Yao Cheng-Jun, Zhuang Dong-Xiao, Wang Yin, Tang Wei-Jun, Ren Guang, Yao Yu, Wu Jin-Song, Mao Ying, Zhou Liang- |
|
Isocitrate dehydrogenase 1 Gene Mutation Is Associated with Prognosis in Clinical Low-Grade Gliomas.
PloS one 2015 10 (6): e0130872. Li Ming-Yang, Wang Yin-Yan, Cai Jin-Quan, Zhang Chuan-Bao, Wang Kuan-Yu, Cheng Wen, Liu Yan-Wei, Zhang Wei, Jiang T |
|
PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas.
PloS one 2015 10 (11): e0142750. Nakae Shunsuke, Sasaki Hikaru, Hayashi Saeko, Hattori Natsuki, Kumon Masanobu, Nishiyama Yuya, Adachi Kazuhide, Nagahisa Shinya, Hayashi Takuro, Inamasu Joji, Abe Masato, Hasegawa Mitsuhiro, Hirose Yuic |
|
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Acta neuropathologica communications 2015 3 (1): 88. Draaisma Kaspar, Wijnenga Maarten M J, Weenink Bas, Gao Ya, Smid Marcel, Robe P, van den Bent Martin J, French Pim |
|
Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors.
Acta neuropathologica 2014 Dec 128 (6): 853-62. Mangerel Joshua, Price Aryeh, Castelo-Branco Pedro, Brzezinski Jack, Buczkowicz Pawel, Rakopoulos Patricia, Merino Diana, Baskin Berivan, Wasserman Jonathan, Mistry Matthew, Barszczyk Mark, Picard Daniel, Mack Stephen, Remke Marc, Starkman Hava, Elizabeth Cynthia, Zhang Cindy, Alon Noa, Lees Jodi, Andrulis Irene L, Wunder Jay S, Jabado Nada, Johnston Donna L, Rutka James T, Dirks Peter B, Bouffet Eric, Taylor Michael D, Huang Annie, Malkin David, Hawkins Cynthia, Tabori U |
|
TERT promoter mutations in gliomas, genetic associations and clinico-pathological correlations.
British journal of cancer 2014 Nov 111 (10): 2024-32. Labussière M, Di Stefano A L, Gleize V, Boisselier B, Giry M, Mangesius S, Bruno A, Paterra R, Marie Y, Rahimian A, Finocchiaro G, Houlston R S, Hoang-Xuan K, Idbaih A, Delattre J-Y, Mokhtari K, Sanson |
|
Exome sequencing identifies somatic gain-of-function PPM1D mutations in brainstem gliomas.
Nature genetics 2014 Jul 46 (7): 726-30. Zhang Liwei, Chen Lee H, Wan Hong, Yang Rui, Wang Zhaohui, Feng Jie, Yang Shaohua, Jones Siân, Wang Sizhen, Zhou Weixin, Zhu Huishan, Killela Patrick J, Zhang Junting, Wu Zhen, Li Guilin, Hao Shuyu, Wang Yu, Webb Joseph B, Friedman Henry S, Friedman Allan H, McLendon Roger E, He Yiping, Reitman Zachary J, Bigner Darell D, Yan H |
|
Comparative analyses of individual and multiple alterations of p53, PTEN and p16 in non-small cell lung carcinoma, glioma and breast carcinoma samples.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2014 Jun 68 (5): 521-6. Stankovic Tijana, Milinkovic Vedrana, Bankovic Jasna, Dinic Jelena, Tanic Nasta, Dramicanin Tatjana, Tanic Niko |
|
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2898-909. Wakimoto Hiroaki, Tanaka Shota, Curry William T, Loebel Franziska, Zhao Dan, Tateishi Kensuke, Chen Juxiang, Klofas Lindsay K, Lelic Nina, Kim James C, Dias-Santagata Dora, Ellisen Leif W, Borger Darrell R, Fendt Sarah-Maria, Vander Heiden Matthew G, Batchelor Tracy T, Iafrate A John, Cahill Daniel P, Chi Andrew |
|
TP53 and p53 statuses and their clinical impact in diffuse low grade gliomas.
Journal of neuro-oncology 2014 May 118 (1): 131-9. Gillet Emeline, Alentorn Agusti, Doukouré Brahima, Mundwiller Emeline, van Thuijl Hinke F, van Thuij Hinke, Reijneveld Jaap C, Medina José Alfonso Meza, Liou Amélie, Marie Yannick, Mokhtari Karima, Hoang-Xuan Khê, Sanson Marc, Delattre Jean-Yves, Idbaih Ahm |
|
The effects of p53 Arg72Pro polymorphism on glioma susceptibility: a meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Apr 35 (4): 3725-30. Zhu Weijie, Lu Lei, Li Yi, Yao Jie, Xu Bain |
|
TP53 promoter methylation in primary glioblastoma: relationship with TP53 mRNA and protein expression and mutation status.
DNA and cell biology 2014 Apr 33 (4): 217-26. Jesionek-Kupnicka Dorota, Szybka Malgorzata, Malachowska Beata, Fendler Wojciech, Potemski Piotr, Piaskowski Sylwester, Jaskolski Dariusz, Papierz Wielislaw, Skowronski Wieslaw, Och Waldemar, Kordek Radzislaw, Zawlik Izabe |
|
Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.
Cancer cell 2014 Mar 25 (3): 393-405. Kool Marcel, Jones David T W, Jäger Natalie, Northcott Paul A, Pugh Trevor J, Hovestadt Volker, Piro Rosario M, Esparza L Adriana, Markant Shirley L, Remke Marc, Milde Till, Bourdeaut Franck, Ryzhova Marina, Sturm Dominik, Pfaff Elke, Stark Sebastian, Hutter Sonja, Seker-Cin Huriye, Johann Pascal, Bender Sebastian, Schmidt Christin, Rausch Tobias, Shih David, Reimand Jüri, Sieber Laura, Wittmann Andrea, Linke Linda, Witt Hendrik, Weber Ursula D, Zapatka Marc, König Rainer, Beroukhim Rameen, Bergthold Guillaume, van Sluis Peter, Volckmann Richard, Koster Jan, Versteeg Rogier, Schmidt Sabine, Wolf Stephan, Lawerenz Chris, Bartholomae Cynthia C, von Kalle Christof, Unterberg Andreas, Herold-Mende Christel, Hofer Silvia, Kulozik Andreas E, von Deimling Andreas, Scheurlen Wolfram, Felsberg Jörg, Reifenberger Guido, Hasselblatt Martin, Crawford John R, Grant Gerald A, Jabado Nada, Perry Arie, Cowdrey Cynthia, Croul Sydney, Zadeh Gelareh, Korbel Jan O, Doz Francois, Delattre Olivier, Bader Gary D, McCabe Martin G, Collins V Peter, Kieran Mark W, Cho Yoon-Jae, Pomeroy Scott L, Witt Olaf, Brors Benedikt, Taylor Michael D, Schüller Ulrich, Korshunov Andrey, Eils Roland, Wechsler-Reya Robert J, Lichter Peter, Pfister Stefan M, |
|
H3F3A K27M mutations in thalamic gliomas from young adult patients.
Neuro-oncology 2014 Jan 16 (1): 140-6. Aihara Koki, Mukasa Akitake, Gotoh Kengo, Saito Kuniaki, Nagae Genta, Tsuji Shingo, Tatsuno Kenji, Yamamoto Shogo, Takayanagi Shunsaku, Narita Yoshitaka, Shibui Soichiro, Aburatani Hiroyuki, Saito Nobuhi |
|
Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 Jan 35 (1): 747-51. Zhang Feng, Li Danni, Li Yanshuang, Li Haixia, Sun Jinbo, Li Xianfeng, Li Xiaoho |
|
IDH mutations: genotype-phenotype correlation and prognostic impact.
BioMed research international 2014 2014 540236. Wang Xiao-Wei, Ciccarino Pietro, Rossetto Marta, Boisselier Blandine, Marie Yannick, Desestret Virginie, Gleize Vincent, Mokhtari Karima, Sanson Marc, Labussière Marian |
|
IDH1/IDH2 but not TP53 mutations predict prognosis in Bulgarian glioblastoma patients.
BioMed research international 2014 2014 654727. Stancheva Gergana, Goranova Teodora, Laleva Maria, Kamenova Margarita, Mitkova Atanaska, Velinov Nikolay, Poptodorov George, Mitev Vanio, Kaneva Radka, Gabrovsky Nikol |
|
Prognostic value of MGMT promoter methylation and TP53 mutation in glioblastomas depends on IDH1 mutation.
Asian Pacific journal of cancer prevention : APJCP 2014 15 (24): 10893-8. Wang Kai, Wang Yin-Yan, Ma Jun, Wang Jiang-Fei, Li Shao-Wu, Jiang Tao, Dai Jian-Pi |
|
TERT promoter mutations in primary and secondary glioblastomas.
Acta neuropathologica 2013 Dec 126 (6): 931-7. Nonoguchi Naosuke, Ohta Takashi, Oh Ji-Eun, Kim Young-Ho, Kleihues Paul, Ohgaki Hiro |
|
P53 codon 72 Arg/Pro polymorphism and glioma risk: an updated meta-analysis.
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 3121-30. He Fang, Xia Yi, Liu Huafeng, Li Jin, Wang Ch |
|
Long-term survival in primary glioblastoma with versus without isocitrate dehydrogenase mutations.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Sep 19 (18): 5146-57. Hartmann Christian, Hentschel Bettina, Simon Matthias, Westphal Manfred, Schackert Gabriele, Tonn Jörg C, Loeffler Markus, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Weller Michael, |
|
Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Aug 31 (23): 2927-35. Zhukova Nataliya, Ramaswamy Vijay, Remke Marc, Pfaff Elke, Shih David J H, Martin Dianna C, Castelo-Branco Pedro, Baskin Berivan, Ray Peter N, Bouffet Eric, von Bueren André O, Jones David T W, Northcott Paul A, Kool Marcel, Sturm Dominik, Pugh Trevor J, Pomeroy Scott L, Cho Yoon-Jae, Pietsch Torsten, Gessi Marco, Rutkowski Stefan, Bognar Laszlo, Klekner Almos, Cho Byung-Kyu, Kim Seung-Ki, Wang Kyu-Chang, Eberhart Charles G, Fevre-Montange Michelle, Fouladi Maryam, French Pim J, Kros Max, Grajkowska Wieslawa A, Gupta Nalin, Weiss William A, Hauser Peter, Jabado Nada, Jouvet Anne, Jung Shin, Kumabe Toshihiro, Lach Boleslaw, Leonard Jeffrey R, Rubin Joshua B, Liau Linda M, Massimi Luca, Pollack Ian F, Shin Ra Young, Van Meir Erwin G, Zitterbart Karel, Schüller Ulrich, Hill Rebecca M, Lindsey Janet C, Schwalbe Ed C, Bailey Simon, Ellison David W, Hawkins Cynthia, Malkin David, Clifford Steven C, Korshunov Andrey, Pfister Stefan, Taylor Michael D, Tabori U |
|
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas.
Oncogene 2013 Jun 32 (25): 3091-100. Wang P, Dong Q, Zhang C, Kuan P-F, Liu Y, Jeck W R, Andersen J B, Jiang W, Savich G L, Tan T-X, Auman J T, Hoskins J M, Misher A D, Moser C D, Yourstone S M, Kim J W, Cibulskis K, Getz G, Hunt H V, Thorgeirsson S S, Roberts L R, Ye D, Guan K-L, Xiong Y, Qin L-X, Chiang D |
|
Low penetrance susceptibility to glioma is caused by the TP53 variant rs78378222.
British journal of cancer 2013 May 108 (10): 2178-85. Enciso-Mora V, Hosking F J, Di Stefano A L, Zelenika D, Shete S, Broderick P, Idbaih A, Delattre J-Y, Hoang-Xuan K, Marie Y, Labussière M, Alentorn A, Ciccarino P, Rossetto M, Armstrong G, Liu Y, Gousias K, Schramm J, Lau C, Hepworth S J, Schoemaker M, Strauch K, Müller-Nurasyid M, Schreiber S, Franke A, Moebus S, Eisele L, Swerdlow A, Simon M, Bondy M, Lathrop M, Sanson M, Houlston R |
|
TP53 and RPA3 gene variations were associated with risk of glioma in a Chinese Han population.
Cancer biotherapy & radiopharmaceuticals 2013 Apr 28 (3): 248-53. Jin Tianbo, Zhang Jiayi, Li Gang, Li Shanqu, Yang Bo, Chen Chao, Cai Lin |
|
Clinicopathological features and molecular analysis of primary glioblastomas in Moroccan patients.
Journal of molecular neuroscience : MN 2013 Mar 49 (3): 567-73. Hilmani Said, Abidi Omar, Benrahma Houda, Karkouri Mehdi, Sahraoui Souha, El Azhari Abdessamad, Barakat Abdelham |
|
Secondary glioblastomas with IDH1/2 mutations have longer glioma history from preceding lower-grade gliomas.
Brain tumor pathology 2013 Mar . Ohno M, Narita Y, Miyakita Y, Matsushita Y, Yoshida A, Fukushima S, Ichimura K, Shibui S |
|
Analysis of 60 Reported Glioma Risk SNPs Replicates Published GWAS Findings but Fails to Replicate Associations From Published Candidate-Gene Studies.
Genetic epidemiology 2013 Feb 37 (2): 2. Walsh KM, Anderson E, Hansen HM, Decker PA, Kosel ML, Kollmeyer T, Rice T, Zheng S, Xiao Y, Chang JS, McCoy LS, Bracci PM, Wiemels JL, Pico AR, Smirnov I, Lachance DH, Sicotte H, Eckel-Passow JE, Wiencke JK, Jenkins RB, Wrensch MR |
|
CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
Neuropathology : official journal of the Japanese Society of Neuropathology 2013 Jan . Purkait S, Jha P, Sharma MC, Suri V, Sharma M, Kale SS, Sarkar C |
|
IDH1/IDH2 mutations define the prognosis and molecular profiles of patients with gliomas: a meta-analysis.
PloS one 2013 8 (7): e68782. Zou Peng, Xu Haitao, Chen Pin, Yan Qing, Zhao Lin, Zhao Peng, Gu Aih |
|
Influence of GSTM1 and GSTT1 polymorphisms on the survival rate of patients with malignant glioma under perillyl alcohol-based therapy.
Genetics and molecular research : GMR 2013 12 (2): 1621-30. Silva M M, Da Fonseca C O, Moura-Neto R, Carvalho J F, Quirico-Santos T, Carvalho M |
|
Promoter hypermethylation of the EMP3 gene in a series of 229 human gliomas.
BioMed research international 2013 2013 756302. Mellai Marta, Piazzi Angela, Caldera Valentina, Annovazzi Laura, Monzeglio Oriana, Senetta Rebecca, Cassoni Paola, Schiffer Davi |
|
Screening for EGFR amplifications with a novel method and their significance for the outcome of glioblastoma patients.
PloS one 2013 8 (6): e65444. Bie?kowski Micha?, Piaskowski Sylwester, Stoczy?ska-Fidelus Ewelina, Szybka Ma?gorzata, Banaszczyk Mateusz, Witusik-Perkowska Monika, Jesie?-Lewandowicz Emilia, Jaskólski Dariusz J, Radomiak-Za?uska Anna, Jesionek-Kupnicka Dorota, Sikorska Beata, Papierz Wielis?aw, Rieske Piotr, Liberski Pawe? |
|
IDH1/2 gene status defines the prognosis and molecular profiles in patients with grade III gliomas.
International journal of clinical oncology 2012 Dec 17 (6): 551-61. Shibahara Ichiyo, Sonoda Yukihiko, Kanamori Masayuki, Saito Ryuta, Yamashita Yoji, Kumabe Toshihiro, Watanabe Mika, Suzuki Hiroyoshi, Kato Shunsuke, Ishioka Chikashi, Tominaga Tei |
|
IDH1 mutation of gliomas with long-term survival analysis.
Oncology reports 2012 Nov 28 (5): 1639-44. Myung Jae Kyung, Cho Hwa Jin, Park Chul-Kee, Kim Seung-Ki, Phi Ji Hoon, Park Sung-H |
|
TP53 mutations in astrocytic gliomas: an association with histological grade, TP53 codon 72 polymorphism and p53 expression.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2012 Nov 120 (11): 882-9. Faria Mario H G, Neves Filho Eduardo H C, Alves Markenia K S, Burbano Rommel M R, de Moraes Filho Manoel O, Rabenhorst Silvia H |
|
Prognostic value of the TP53 Arg72Pro single-nucleotide polymorphism and susceptibility to medulloblastoma in a cohort of Brazilian patients.
Journal of neuro-oncology 2012 Oct 110 (1): 49-57. Carvalho Raimundo M, Pinto Giovanny R, Yoshioka France K N, Lima Patrícia D L, Souza Carolina R T, Guimarães Adriana C, Lamarão Letícia M, Rey Juan A, Burbano Rommel |
|
Rare TP53 genetic variant associated with glioma risk and outcome.
Journal of medical genetics 2012 Jul 49 (7): 420-1. Egan Kathleen M, Nabors L Burton, Olson Jeffrey J, Monteiro Alvaro N, Browning James E, Madden Melissa H, Thompson Reid |
|
1P19Q loss but not IDH1 mutations influences WHO grade II gliomas spontaneous growth.
Journal of neuro-oncology 2012 May 108 (1): 69-75. Gozé Catherine, Bezzina Charlotte, Gozé Eric, Rigau Valérie, Maudelonde Thierry, Bauchet Luc, Duffau Hugu |
|
Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients.
Cancer science 2012 Mar 103 (3): 587-92. Mukasa Akitake, Takayanagi Shunsaku, Saito Kuniaki, Shibahara Junji, Tabei Yusuke, Furuya Kazuhide, Ide Takafumi, Narita Yoshitaka, Nishikawa Ryo, Ueki Keisuke, Saito Nobuhi |
|
TP53 codon 72 polymorphism and glioma risk: A meta-analysis.
Oncology letters 2012 Mar 3 (3): 599-606. Shi Minghan, Huang Ruishan, Pei Chunying, Jia Xiuzhi, Jiang Chuanlu, Ren Hu |
|
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma.
Nature 2012 Feb 482 (7384): 226-31. Schwartzentruber Jeremy, Korshunov Andrey, Liu Xiao-Yang, Jones David T W, Pfaff Elke, Jacob Karine, Sturm Dominik, Fontebasso Adam M, Quang Dong-Anh Khuong, Tönjes Martje, Hovestadt Volker, Albrecht Steffen, Kool Marcel, Nantel Andre, Konermann Carolin, Lindroth Anders, Jäger Natalie, Rausch Tobias, Ryzhova Marina, Korbel Jan O, Hielscher Thomas, Hauser Peter, Garami Miklos, Klekner Almos, Bognar Laszlo, Ebinger Martin, Schuhmann Martin U, Scheurlen Wolfram, Pekrun Arnulf, Frühwald Michael C, Roggendorf Wolfgang, Kramm Christoph, Dürken Matthias, Atkinson Jeffrey, Lepage Pierre, Montpetit Alexandre, Zakrzewska Magdalena, Zakrzewski Krzystof, Liberski Pawel P, Dong Zhifeng, Siegel Peter, Kulozik Andreas E, Zapatka Marc, Guha Abhijit, Malkin David, Felsberg Jörg, Reifenberger Guido, von Deimling Andreas, Ichimura Koichi, Collins V Peter, Witt Hendrik, Milde Till, Witt Olaf, Zhang Cindy, Castelo-Branco Pedro, Lichter Peter, Faury Damien, Tabori Uri, Plass Christoph, Majewski Jacek, Pfister Stefan M, Jabado Na |
|
IDH mutations predict longer survival and response to temozolomide in secondary glioblastoma.
Cancer science 2012 Feb 103 (2): 269-73. SongTao Qi, Lei Yu, Si Gui, YanQing Ding, HuiXia Han, XueLin Zhang, LanXiao Wu, Fei Y |
|
IDH1 mutations in grade II astrocytomas are associated with unfavorable progression-free survival and prolonged postrecurrence survival.
Cancer 2012 Jan 118 (2): 452-60. Thon Niklas, Eigenbrod Sabina, Kreth Simone, Lutz Juergen, Tonn Joerg-Christian, Kretzschmar Hans, Peraud Aurelia, Kreth Friedrich-Wilhe |
|
Association of p53 Arg72Pro and MDM2 SNP309 polymorphisms with glioma.
Genetics and molecular research : GMR 2012 11 (4): 3618-28. Zhang J N, Yi S H, Zhang X H, Liu X Y, Mao Q, Li S Q, Xiong W H, Qiu Y M, Chen T, Ge J |
|
Characterization of molecular genetic alterations in GBMs highlights a distinctive molecular profile in young adults.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2011 Dec 20 (4): 225-32. Jha Prerana, Suri Vaishali, Singh Geetika, Jha Pankaj, Purkait Suvendu, Pathak Pankaj, Sharma Vikas, Sharma Mehar Chand, Suri Ashish, Gupta Deepak, Mahapatra Ashok Kumar, Sarkar Chit |
A germline variant in the TP53 polyadenylation signal confers cancer susceptibility.
Nature genetics 2011 Nov 43 (11): 1098-103. Stacey Simon N, Sulem Patrick, Jonasdottir Aslaug, Masson Gisli, Gudmundsson Julius, Gudbjartsson Daniel F, Magnusson Olafur T, Gudjonsson Sigurjon A, Sigurgeirsson Bardur, Thorisdottir Kristin, Ragnarsson Rafn, Benediktsdottir Kristrun R, Nexø Bjørn A, Tjønneland Anne, Overvad Kim, Rudnai Peter, Gurzau Eugene, Koppova Kvetoslava, Hemminki Kari, Corredera Cristina, Fuentelsaz Victoria, Grasa Pilar, Navarrete Sebastian, Fuertes Fernando, García-Prats Maria D, Sanambrosio Enrique, Panadero Angeles, De Juan Ana, Garcia Almudena, Rivera Fernando, Planelles Dolores, Soriano Virtudes, Requena Celia, Aben Katja K, van Rossum Michelle M, Cremers Ruben G H M, van Oort Inge M, van Spronsen Dick-Johan, Schalken Jack A, Peters Wilbert H M, Helfand Brian T, Donovan Jenny L, Hamdy Freddie C, Badescu Daniel, Codreanu Ovidiu, Jinga Mariana, Csiki Irma E, Constantinescu Vali, Badea Paula, Mates Ioan N, Dinu Daniela E, Constantin Adrian, Mates Dana, Kristjansdottir Sjofn, Agnarsson Bjarni A, Jonsson Eirikur, Barkardottir Rosa B, Einarsson Gudmundur V, Sigurdsson Fridbjorn, Moller Pall H, Stefansson Tryggvi, Valdimarsson Trausti, Johannsson Oskar T, Sigurdsson Helgi, Jonsson Thorvaldur, Jonasson Jon G, Tryggvadottir Laufey, Rice Terri, Hansen Helen M, Xiao Yuanyuan, Lachance Daniel H, O Neill Brian Patrick, Kosel Matthew L, Decker Paul A, Thorleifsson Gudmar, Johannsdottir Hrefna, Helgadottir Hafdis T, Sigurdsson Asgeir, Steinthorsdottir Valgerdur, Lindblom Annika, , Sandler Robert S, Keku Temitope O, Banasik Karina, Jørgensen Torben, Witte Daniel R, Hansen Torben, Pedersen Oluf, Jinga Viorel, Neal David E, Catalona William J, Wrensch Margaret, Wiencke John, Jenkins Robert B, Nagore Eduardo, Vogel Ulla, Kiemeney Lambertus A, Kumar Rajiv, Mayordomo José I, Olafsson Jon H, Kong Augustine, Thorsteinsdottir Unnur, Rafnar Thorunn, Stefansson Ka |
|
IDH1 and IDH2 mutations, immunohistochemistry and associations in a series of brain tumors.
Journal of neuro-oncology 2011 Nov 105 (2): 345-57. Mellai Marta, Piazzi Angela, Caldera Valentina, Monzeglio Oriana, Cassoni Paola, Valente Guido, Schiffer Davi |
|
IDH1 mutations in gliomas: first series from a tertiary care centre in India with comprehensive review of literature.
Experimental and molecular pathology 2011 Aug 91 (1): 385-93. Jha Prerana, Suri Vaishali, Sharma Vikas, Singh Geetika, Sharma Mehar Chand, Pathak Pankaj, Chosdol Kunzang, Jha Pankaj, Suri Ashish, Mahapatra Ashok Kumar, Kale Shashank Sharad, Sarkar Chit |
|
Molecular markers in low-grade gliomas: predictive or prognostic?
Clinical cancer research : an official journal of the American Association for Cancer Research 2011 Jul 17 (13): 4588-99. Hartmann Christian, Hentschel Bettina, Tatagiba Marcos, Schramm Johannes, Schnell Oliver, Seidel Clemens, Stein Robert, Reifenberger Guido, Pietsch Torsten, von Deimling Andreas, Loeffler Markus, Weller Michael, |
|
TP53 mutations in favorable-risk Wnt/Wingless-subtype medulloblastomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2011 Apr 29 (12): e344-6; author reply e347-8. Lindsey Janet C, Hill Rebecca M, Megahed Hisham, Lusher Meryl E, Schwalbe Ed C, Cole Michael, Hogg Twala L, Gilbertson Richard J, Ellison David W, Bailey Simon, Clifford Steven |
- Page last reviewed:Mar 16, 2019
- Page last updated:Sep 23, 2020
- Content source: